Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes: Further insights into SGLT2 inhibitors.

× No keyword cloud information.

2 in total

1. Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.

Authors: Subodh Verma; C David Mazer; Mohammed Al-Omran; Silvio E Inzucchi; David Fitchett; Uwe Hehnke; Jyothis T George; Bernard Zinman
Journal: Circulation Date: 2017-11-13 Impact factor: 29.690

2. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).

Authors: Kenneth W Mahaffey; Bruce Neal; Vlado Perkovic; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Elisa Fabbrini; Tao Sun; Qiang Li; Mehul Desai; David R Matthews
Journal: Circulation Date: 2017-11-13 Impact factor: 29.690

2 in total

1. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].

Authors: Yufeng Xu; Peili Wu; Weiheng Wen; Hong Chen
Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2019-11-30

2. Biotransformation of Phlorizin by Eurotium cristatum to Increase the Antioxidant and Antibacterial Activity of Docynia indica Leaves.

Authors: Jie Xie; Jiang Chen; Xue-Ran Mei; Ming-Jun Zhu; Xue-Li Li; Juan Du; Xiao-Yu Zhang
Journal: Curr Microbiol Date: 2021-03-08 Impact factor: 2.188

2 in total